CD79A and irritable bowel syndrome: In terms of predictors of responsiveness to a GFD, a prospective study of 50 patients with IBS demonstrated that individuals with antigliadin IgG and IgA reported less diarrhoea than those without antibodies (p = 0.03), using the Birmingham IBS symptom questionnaire [24].